Clinical Trials Directory

Trials / Completed

CompletedNCT02083107

Comparison Between Rectal & Sublingual Misoprostol Before Caesarian Section To Reduce Intra & Post-Operative Blood Loss

COMPARISON BETWEEN RECTAL & SUBLINGUAL MISOPROSTOL BEFORE CAESARIAN SECTION TO REDUCE INTRA & POST-OPERATIVE BLOOD LOSS

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
636 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
Female
Age
18 Years – 38 Years
Healthy volunteers
Accepted

Summary

The aim of the work is to evaluate \& compare the effectiveness of rectally administered PGE1 synthetic analogue (misoprostol) 400 microgram versus sublingually administered misoprostol before caesarean section to decrease blood loss during and after the operation.

Conditions

Interventions

TypeNameDescription
DRUGMisoprostolComparison of different routes of administration of 400 micro gram misoprostol
OTHERPlacebo

Timeline

Start date
2013-02-01
Primary completion
2014-02-01
Completion
2014-02-01
First posted
2014-03-11
Last updated
2015-12-22
Results posted
2014-06-27

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02083107. Inclusion in this directory is not an endorsement.